Alcon Long Term Debt 2019-2026 | ALC
Alcon long term debt from 2019 to 2026. Long term debt can be defined as the sum of all long term debt fields.
- Alcon long term debt for the quarter ending June 30, 2026 was $4.149B, a 11.04% decline year-over-year.
- Alcon long term debt for 2025 was $4.162B, a 8.29% decline from 2024.
- Alcon long term debt for 2024 was $4.538B, a 2.95% decline from 2023.
- Alcon long term debt for 2023 was $4.676B, a 2.97% increase from 2022.
|
Alcon Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2025 | $4,162 |
| 2024 | $4,538 |
| 2023 | $4,676 |
| 2022 | $4,541 |
| 2021 | $3,966 |
| 2020 | $3,949 |
| 2019 | $3,218 |
|
Alcon Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2026-06-30 | $4,149 |
| 2026-03-31 | $4,157 |
| 2025-12-31 | $4,162 |
| 2025-09-30 | $4,163 |
| 2025-06-30 | $4,664 |
| 2025-03-31 | $4,597 |
| 2024-12-31 | $4,538 |
| 2024-09-30 | $4,575 |
| 2024-06-30 | $4,550 |
| 2024-03-31 | $4,553 |
| 2023-12-31 | $4,676 |
| 2023-09-30 | $4,568 |
| 2023-06-30 | $4,581 |
| 2023-03-31 | $4,584 |
| 2022-12-31 | $4,541 |
| 2022-09-30 | $3,853 |
| 2022-06-30 | $3,883 |
| 2022-03-31 | $3,916 |
| 2021-12-31 | $3,966 |
| 2021-09-30 | $3,976 |
| 2021-06-30 | $3,986 |
| 2021-03-31 | $3,979 |
| 2020-12-31 | $3,949 |
| 2020-09-30 | $3,928 |
| 2020-06-30 | $3,909 |
| 2020-03-31 | $3,157 |
| 2019-12-31 | $3,218 |
| 2019-09-30 | $3,216 |
| 2019-06-30 | $1,751 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $33.505B | $10.401B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.884B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $133.518B | 45.26 |
| Edwards Lifesciences (EW) | United States | $49.242B | 30.43 |
| IQVIA Holdings (IQV) | United States | $43.729B | 23.39 |
| Waters (WAT) | United States | $40.283B | 29.97 |
| IDEXX Laboratories (IDXX) | United States | $40.144B | 35.83 |
| DexCom (DXCM) | United States | $31.955B | 33.21 |
| Mettler-Toledo (MTD) | United States | $25.762B | 28.65 |
| STERIS (STE) | Ireland | $20.832B | 20.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.759B | 0.00 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $14.762B | 17.70 |
| Penumbra (PEN) | United States | $12.599B | 83.08 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.279B | 8.59 |
| Globus Medical (GMED) | United States | $10.173B | 15.40 |
| Glaukos (GKOS) | United States | $10.092B | 0.00 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.390B | 27.95 |
| Teleflex (TFX) | United States | $5.521B | 14.89 |
| LivaNova (LIVN) | United Kingdom | $4.442B | 22.46 |
| Integer Holdings (ITGR) | United States | $4.287B | 19.86 |
| Pulse Biosciences (PLSE) | United States | $3.752B | 0.00 |
| Veracyte (VCYT) | United States | $3.313B | 27.11 |
| TransMedics (TMDX) | United States | $2.967B | 43.58 |
| AxoGen (AXGN) | United States | $2.354B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.153B | 27.17 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 17.62 |
| Nihon Kohden (NHNKY) | Japan | $1.694B | 15.52 |
| Alphatec Holdings (ATEC) | United States | $1.677B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.301B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.36 |
| Artivion (AORT) | United States | $1.217B | 46.24 |
| PROCEPT BioRobotics (PRCT) | United States | $1.204B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Tandem Diabetes Care (TNDM) | United States | $1.170B | 0.00 |
| OPKO Health (OPK) | United States | $1.164B | 0.00 |
| IRadimed (IRMD) | United States | $1.055B | 46.11 |
| Anteris Technologies Global (AVR) | Australia | $0.850B | 0.00 |
| SiBone (SIBN) | United States | $0.829B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.753B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.680B | 16.37 |
| AngioDynamics (ANGO) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.583B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.570B | 1644.00 |
| Tactile Systems Technology (TCMD) | United States | $0.511B | 20.90 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.448B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.420B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.411B | 0.00 |
| 908 Devices (MASS) | United States | $0.402B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.371B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.334B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.301B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.266B | 0.00 |
| RxSight (RXST) | United States | $0.254B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.159B | 0.00 |
| FocalTherics (FOCL) | France | $0.154B | 0.00 |
| Inogen (INGN) | United States | $0.139B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Hyperfine (HYPR) | United States | $0.085B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.083B | 0.00 |
| CVRx (CVRX) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 23.27 |
| DarioHealth (DRIO) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.059B | 0.00 |
| Envoy Medical (COCH) | United States | $0.056B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| InspireMD (NSPR) | United States | $0.038B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.036B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Accuray (ARAY) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |